Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (221-230 of 339) with videos related to

Pageof 34
Sort By:
The Lancet. Oncology|July 11, 2014
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trialsRobert K Hills, Sylvie Castaigne, Frederick R Appelbaum, et al.
The New England Journal of Medicine|September 8, 2016
Cord-Blood Transplantation in Patients with Minimal Residual DiseaseFilippo Milano, Ted Gooley, Brent Wood, et al.
Blood|May 28, 2009
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHDAfonso C Vigorito, Paulo V Campregher, Barry E Storer, et al.
Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Blood and marrow transplant clinical trials network state of the Science Symposium 2014Frederick R Appelbaum, Claudio Anasetti, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2015
Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantationBrandon K C Au, Ted A Gooley, Philippe Armand, et al.
Blood|January 18, 2013
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patientsRoland B Walter, Megan Othus, Alan K Burnett, et al.
Blood|April 18, 2013
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H Petersdorf, Kenneth J Kopecky, Marilyn Slovak, et al.
Blood|August 24, 2012
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemiaJerald P Radich, Kenneth J Kopecky, Frederick R Appelbaum, et al.
Blood|August 14, 2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710Bayard L Powell, Barry Moser, Wendy Stock, et al.
Pageof 34

Showing results (221-230 of 339) with videos related to

Sort By:
Pageof 34
The Lancet. Oncology|July 11, 2014
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trialsRobert K Hills, Sylvie Castaigne, Frederick R Appelbaum, et al.
The New England Journal of Medicine|September 8, 2016
Cord-Blood Transplantation in Patients with Minimal Residual DiseaseFilippo Milano, Ted Gooley, Brent Wood, et al.
Blood|May 28, 2009
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHDAfonso C Vigorito, Paulo V Campregher, Barry E Storer, et al.
Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Blood and marrow transplant clinical trials network state of the Science Symposium 2014Frederick R Appelbaum, Claudio Anasetti, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2015
Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantationBrandon K C Au, Ted A Gooley, Philippe Armand, et al.
Blood|January 18, 2013
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patientsRoland B Walter, Megan Othus, Alan K Burnett, et al.
Blood|April 18, 2013
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H Petersdorf, Kenneth J Kopecky, Marilyn Slovak, et al.
Blood|August 24, 2012
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemiaJerald P Radich, Kenneth J Kopecky, Frederick R Appelbaum, et al.
Blood|August 14, 2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710Bayard L Powell, Barry Moser, Wendy Stock, et al.
Pageof 34